封面
市場調查報告書
商品編碼
2149270

中國倉鼠卵巢細胞市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測

Chinese Hamster Ovary Cell Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034

出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

中國倉鼠卵巢細胞市場成長要素

2025年全球中國倉鼠卵巢細胞(CHO細胞)市場規模為57.8億美元。預計該市場將從2026年的63.6億美元成長至2034年的141.3億美元,預測期內年複合成長率(CAGR)為10.50%。2025年,北美市場佔據43.77%的市場佔有率,市場規模約25.3億美元,成為全球市場的主要驅動力。中國倉鼠卵巢細胞(CHO細胞)廣泛應用於生物製藥的生產,特別是單株抗體和重組治療性蛋白質的生產。生物製藥產品線的拓展、生物相似藥的開發、外包給合約研究組織(CRO)和合約研發生產組織(CDMO)的業務,以及對CHO培養基、飼養層細胞、添加劑和表達系統的持續需求,都在推動市場成長。

基於CHO細胞的平台使製藥和生物技術公司能夠開發穩定的細胞株,並實現複雜治療性蛋白質的商業化生產。市場涵蓋CHO細胞株、培養基、表達系統、載體、篩選系統、飼養層細胞、補充劑、細胞株開發服務和製程開發支援。此外,對先進表達技術的投資不斷增加,促使供應商提供整合的CHO細胞平台,而非單一產品。

市場定義和範圍

中國倉鼠卵巢細胞(CHO)市場涵蓋用於CHO細胞株開發、生物製藥研究、製程最佳化以及臨床和商業生物生產的產品和服務。該市場依產品、工作流程、應用和最終用戶細分。應用包括單株抗體生產、重組蛋白生產、生物相似藥開發、毒性測試和基礎研究。

該市場的目標客戶包括製藥公司、生物技術公司、合約研究組織(CRO)和合約研發生產力組織(CDMO)、研究機構和學術機構。對穩定性、擴充性和高生產力細胞株的需求不斷成長,正推動 CHO 細胞平台在整個生物製藥開發生命週期中的應用日益廣泛。

市場動態

促進因素

單株抗體和重組生物製藥產品線的不斷擴展是市場成長的主要驅動力。 CHO細胞廣泛用於抗體表現、穩定細胞株建構、製程最佳化和大規模生產。此外,由於專利到期,生物相似藥和生物製藥的開發日益增多,這也持續推高了對基於CHO細胞的技術和服務的需求。

趨勢

關鍵趨勢之一是轉型至整合式CHO細胞表達平台,該平台整合了宿主細胞、載體、分選系統、最佳化培養基、飼養層細胞和製程開發支援。此類平台目的是縮短克隆篩檢時間、提高表達穩定性、提高生產效率並加速生物製藥開發。2025年9月,WuXi Biologics推出了其第四代標靶整合式CHO細胞株平台TrueSite TI。

阻礙因素

CHO細胞株的高成本和漫長的研發、克隆篩檢、製程最佳化和規模化生產仍然是主要阻礙因素。複雜的法規和品質要求進一步增加了研發成本。與HEK293、微生物、酵母和昆蟲細胞表現系統的競爭也可能限制CHO細胞在某些應用中的使用。

機會與挑戰

外包給合約研究組織(CRO)和合約研發生產機構(CDMO)的做法日益增多,為缺乏內部 CHO 細胞開發能力的中小型生物技術公司創造了巨大的機會。涵蓋細胞株開發、GMP 規模化生產、細胞庫建構和生產製造的綜合服務能夠顯著提高開發效率。然而,替代表達系統仍然是個挑戰,因為某些分子使用其他平台可以更有效率地生產。

新冠疫情的影響

新冠疫情對生物製藥的研發、生產、供應鏈和實驗室運作造成了全面衝擊。然而,生物製藥生產和治療藥物研發的重要性支撐了對細胞培養技術的持續投資。隨著藥物研發活動的逐步恢復,對採用CHO細胞的生物製藥研發和生產基礎設施的需求也隨之成長。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會
  • 市場挑戰
  • 市場趨勢

第4章 主要考察

  • CHO細胞株的技術進步
  • 主要產業趨勢(合併、收購、合作等)
  • 新產品發布:依主要公司分類
  • CHO細胞開發監管指南

第5章 全球中國倉鼠卵巢細胞市場分析、洞察與預測(2021-2034)

  • 市場分析、洞察與預測:依產品/服務分類。
    • 服務
  • 市場分析、洞察與預測:依工作流程
    • 瞬態發生
    • 穩定細胞株的構建
    • 製程開發和規模化
    • 商業/臨床生物生產支持
    • 其他
  • 市場分析、洞察與預測:依應用領域分類
    • 單株抗體(MAbs)的生產
    • 重組蛋白生產
    • 生物相似藥的開發
    • 毒理學和基礎研究
    • 其他
  • 市場分析、洞察與預測:依最終用戶分類
    • 製藥和生物技術公司
    • CRO/CDMO
    • 學術研究機構
    • 其他
  • 分析、洞察與預測:依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美中國倉鼠卵巢細胞市場分析、洞察與預測(2021-2034)

  • 國家
    • 美國
    • 加拿大

第7章 中國倉鼠卵巢細胞在歐洲市場的分析、洞察與預測(2021-2034年)

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章 亞太地區中國倉鼠卵巢細胞市場:分析、洞察與預測(2021-2034)

  • 國家
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章 拉丁美洲中國倉鼠卵巢細胞市場分析、洞察與預測(2021-2034)

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中國倉鼠卵巢細胞市場在中東和非洲的分析、洞察與預測(2021-2034年)

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Sartorius AG
    • Lonza
    • American Type Culture Collection
    • FUJIFILM Corporation
    • WuXi Biologics.
    • AGC Biologics
    • Charles River Laboratories
Product Code: FBI118693

Growth Factors of Chinese hamster ovary cell Market

The global Chinese hamster ovary cell market size was valued at USD 5.78 billion in 2025. The market is projected to grow from USD 6.36 billion in 2026 to USD 14.13 billion by 2034, exhibiting a CAGR of 10.50% during the forecast period. North America dominated the global market with a 43.77% share in 2025, valued at approximately USD 2.53 billion. Chinese Hamster Ovary (CHO) cells are widely used in biopharmaceutical manufacturing, particularly for monoclonal antibodies and recombinant therapeutic proteins. Growing biologics pipelines, biosimilar development, outsourcing to CROs and CDMOs, and recurring demand for CHO media, feeds, supplements, and expression systems are supporting market growth.

CHO-based platforms enable pharmaceutical and biotechnology companies to develop stable cell lines and manufacture complex therapeutic proteins at commercial scale. The market includes CHO cell lines, culture media, expression systems, vectors, selection systems, feeds, supplements, cell-line development services, and process-development support. Increasing investments in advanced expression technologies are also encouraging suppliers to offer integrated CHO platforms rather than individual products.

Market Definition and Scope

The Chinese hamster ovary cell market comprises products and services used for CHO-based cell-line development, biologics research, process optimization, and clinical or commercial bioproduction. The market is segmented by offering, workflow, application, and end user. Applications include monoclonal antibody production, recombinant protein production, biosimilar development, toxicology, and basic research.

The market serves pharmaceutical and biotechnology companies, CROs and CDMOs, research institutions, and academic organizations. Increasing demand for stable, scalable, and high-productivity cell lines is expanding the use of CHO platforms across the biologics development lifecycle.

Market Dynamics

Drivers

The growing monoclonal antibody and recombinant biologics pipeline is a major driver of market expansion. CHO cells are extensively used for antibody expression, stable cell-line development, process optimization, and large-scale manufacturing. The increasing development of biosimilars and biologics following patent expiries is also creating recurring demand for CHO-based technologies and services.

Trends

A significant trend is the shift toward integrated CHO expression platforms combining host cells, vectors, selection systems, optimized media, feeds, and process-development support. Such platforms aim to reduce clone-screening time, improve expression stability, increase productivity, and accelerate biologics development. In September 2025, WuXi Biologics launched its TrueSite TI fourth-generation targeted-integration CHO cell-line platform.

Restraints

High costs and long timelines associated with CHO cell-line development, clone screening, process optimization, and scale-up remain key restraints. Complex regulatory and quality requirements further increase development costs. Competition from HEK293, microbial, yeast, and insect-cell expression systems can also limit CHO adoption for certain applications.

Opportunities and Challenges

Growing outsourcing to CROs and CDMOs creates significant opportunities, particularly for small and mid-sized biotechnology companies lacking internal CHO capabilities. Integrated services covering cell-line development, GMP scale-up, cell banking, and manufacturing can improve development efficiency. However, alternative expression systems remain a challenge because some molecules may be produced more efficiently using other platforms.

Impact of COVID-19

The COVID-19 pandemic created disruptions across biopharmaceutical research, manufacturing, supply chains, and laboratory operations. However, the importance of biologics manufacturing and therapeutic development supported continued investment in cell-based production technologies. As pharmaceutical development activities normalized, demand for CHO-based biologics development and manufacturing infrastructure increased.

Segmentation Analysis

By offering, products dominated the market in 2025, supported by recurring consumption of CHO media, feeds, cell lines, expression systems, and development kits. The services segment is projected to grow at a CAGR of 11.83% through 2034.

By workflow, commercial/clinical bioproduction support dominated in 2025 and is expected to hold a 29.5% share in 2026. Process development and scale-up is projected to grow at a CAGR of 11.73%.

By application, monoclonal antibody production dominated in 2025, with the segment expected to hold a 46.5% share in 2026. Biosimilar development is projected to grow at a CAGR of 15.50%.

By end user, pharmaceutical and biotechnology companies dominated in 2025 and are expected to hold a 52.9% share in 2026. CROs/CDMOs are projected to grow at a CAGR of 13.35%.

Regional Insights

North America dominated the global market with USD 2.53 billion in 2025, supported by a strong biologics pipeline, major pharmaceutical and biotechnology companies, advanced CHO technologies, and increasing biosimilar activity. The U.S. market is estimated at USD 2.49 billion in 2026.

Asia Pacific is expected to be the fastest-growing regional market and is projected to reach USD 1.40 billion in 2026. China, Japan, and India are estimated at USD 0.53 billion, USD 0.36 billion, and USD 0.19 billion, respectively, in 2026. Europe is projected to grow at a 9.72% CAGR, supported by its mature biosimilar ecosystem and established biologics manufacturing base.

Competitive Landscape

Key companies include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Sartorius AG, Lonza, American Type Culture Collection, FUJIFILM Corporation, WuXi Biologics, AGC Biologics, and Charles River Laboratories. Companies are focusing on high-productivity CHO cell lines, integrated expression platforms, optimized media and feeds, targeted integration, and outsourced cell-line development services.

Report Coverage

The report covers the global Chinese hamster ovary cell market size and forecast for 2025, 2026, and 2034, along with market dynamics, trends, drivers, restraints, opportunities, challenges, segmentation by offering, workflow, application, and end user, regional analysis, competitive landscape, key industry developments, and company profiles.

Conclusion

The global Chinese hamster ovary cell market is projected to expand from USD 5.78 billion in 2025 to USD 6.36 billion in 2026 and USD 14.13 billion by 2034, registering a 10.50% CAGR. Rising monoclonal antibody development, biosimilar pipelines, biologics manufacturing, CRO/CDMO outsourcing, and integrated CHO expression platforms are expected to support sustained market expansion. North America remained the leading regional market in 2025, while Asia Pacific is expected to experience strong growth through 2034. Continued innovation in high-productivity cell lines, media, feeds, and development services is expected to remain important to the market.

Segmentation By Offering, Workflow, Application, End User, and Region

By Offering

  • Products
    • CHO Cell Lines
    • Cell Culture Media
    • Expression Systems & Cell Line Development Kits
    • Vectors & Selection Systems
    • Feeds & Supplements
    • Others
  • Services

By Workflow

  • Transient Expression
  • Stable Cell Line Development
  • Process Development & Scale-up
  • Commercial/Clinical Bioproduction Support
  • Others

By Application

  • MAb Production
  • Recombinant Protein Production
  • Biosimilar Development
  • Toxicology & Basic Research
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • CROs/CDMOs
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Offering, Workflow, Application, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Offering, Workflow, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Workflow, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Workflow, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Workflow, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Challenges
  • 3.5. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in CHO Cell Lines
  • 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.3. New Product Launches, By Key Players
  • 4.4. Regulatory Guidelines in CHO Cell Development

5. Global Chinese Hamster Ovary Cell Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Products
      • 5.1.1.1. CHO Cell Lines
      • 5.1.1.2. Cell Culture Media
      • 5.1.1.3. Expression Systems & Cell Line Development Kits
      • 5.1.1.4. Vectors & Selection Systems
      • 5.1.1.5. Feeds & Supplements
      • 5.1.1.6. Others
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Workflow
    • 5.2.1. Transient Expression
    • 5.2.2. Stable Cell Line Development
    • 5.2.3. Process Development & Scale-up
    • 5.2.4. Commercial / Clinical Bioproduction Support
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. MAb Production
    • 5.3.2. Recombinant Protein Production
    • 5.3.3. Biosimilar Development
    • 5.3.4. Toxicology & Basic Research
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. CROs/CDMOs
    • 5.4.3. Academic & Research Institutes
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Chinese Hamster Ovary Cell Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Products
      • 6.1.1.1. CHO Cell Lines
      • 6.1.1.2. Cell Culture Media
      • 6.1.1.3. Expression Systems & Cell Line Development Kits
      • 6.1.1.4. Vectors & Selection Systems
      • 6.1.1.5. Feeds & Supplements
      • 6.1.1.6. Others
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Workflow
    • 6.2.1. Transient Expression
    • 6.2.2. Stable Cell Line Development
    • 6.2.3. Process Development & Scale-up
    • 6.2.4. Commercial / Clinical Bioproduction Support
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. MAb Production
    • 6.3.2. Recombinant Protein Production
    • 6.3.3. Biosimilar Development
    • 6.3.4. Toxicology & Basic Research
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. CROs/CDMOs
    • 6.4.3. Academic & Research Institutes
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Chinese Hamster Ovary Cell Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Products
      • 7.1.1.1. CHO Cell Lines
      • 7.1.1.2. Cell Culture Media
      • 7.1.1.3. Expression Systems & Cell Line Development Kits
      • 7.1.1.4. Vectors & Selection Systems
      • 7.1.1.5. Feeds & Supplements
      • 7.1.1.6. Others
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Workflow
    • 7.2.1. Transient Expression
    • 7.2.2. Stable Cell Line Development
    • 7.2.3. Process Development & Scale-up
    • 7.2.4. Commercial / Clinical Bioproduction Support
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. MAb Production
    • 7.3.2. Recombinant Protein Production
    • 7.3.3. Biosimilar Development
    • 7.3.4. Toxicology & Basic Research
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. CROs/CDMOs
    • 7.4.3. Academic & Research Institutes
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Chinese Hamster Ovary Cell Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Products
      • 8.1.1.1. CHO Cell Lines
      • 8.1.1.2. Cell Culture Media
      • 8.1.1.3. Expression Systems & Cell Line Development Kits
      • 8.1.1.4. Vectors & Selection Systems
      • 8.1.1.5. Feeds & Supplements
      • 8.1.1.6. Others
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Workflow
    • 8.2.1. Transient Expression
    • 8.2.2. Stable Cell Line Development
    • 8.2.3. Process Development & Scale-up
    • 8.2.4. Commercial / Clinical Bioproduction Support
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. MAb Production
    • 8.3.2. Recombinant Protein Production
    • 8.3.3. Biosimilar Development
    • 8.3.4. Toxicology & Basic Research
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. CROs/CDMOs
    • 8.4.3. Academic & Research Institutes
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Chinese Hamster Ovary Cell Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Products
      • 9.1.1.1. CHO Cell Lines
      • 9.1.1.2. Cell Culture Media
      • 9.1.1.3. Expression Systems & Cell Line Development Kits
      • 9.1.1.4. Vectors & Selection Systems
      • 9.1.1.5. Feeds & Supplements
      • 9.1.1.6. Others
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Workflow
    • 9.2.1. Transient Expression
    • 9.2.2. Stable Cell Line Development
    • 9.2.3. Process Development & Scale-up
    • 9.2.4. Commercial / Clinical Bioproduction Support
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. MAb Production
    • 9.3.2. Recombinant Protein Production
    • 9.3.3. Biosimilar Development
    • 9.3.4. Toxicology & Basic Research
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. CROs/CDMOs
    • 9.4.3. Academic & Research Institutes
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Chinese Hamster Ovary Cell Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Products
      • 10.1.1.1. CHO Cell Lines
      • 10.1.1.2. Cell Culture Media
      • 10.1.1.3. Expression Systems & Cell Line Development Kits
      • 10.1.1.4. Vectors & Selection Systems
      • 10.1.1.5. Feeds & Supplements
      • 10.1.1.6. Others
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Workflow
    • 10.2.1. Transient Expression
    • 10.2.2. Stable Cell Line Development
    • 10.2.3. Process Development & Scale-up
    • 10.2.4. Commercial / Clinical Bioproduction Support
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. MAb Production
    • 10.3.2. Recombinant Protein Production
    • 10.3.3. Biosimilar Development
    • 10.3.4. Toxicology & Basic Research
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. CROs/CDMOs
    • 10.4.3. Academic & Research Institutes
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Merck KGaA
    • 11.2.3. Danaher Corporation
    • 11.2.4. Sartorius AG
    • 11.2.5. Lonza
    • 11.2.6. American Type Culture Collection
    • 11.2.7. FUJIFILM Corporation
    • 11.2.8. WuXi Biologics.
    • 11.2.9. AGC Biologics
    • 11.2.10. Charles River Laboratories

List of Tables

  • Table 1: Global Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 2: Global Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 3: Global Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Workflow, 2021-2034
  • Table 4: Global Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 5: Global Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 6: Global Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 7: North America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 8: North America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 9: North America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Workflow, 2021-2034
  • Table 10: North America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: North America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 12: North America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 14: Europe Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 15: Europe Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Workflow, 2021-2034
  • Table 16: Europe Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 17: Europe Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 18: Europe Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 20: Asia Pacific Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 21: Asia Pacific Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Workflow, 2021-2034
  • Table 22: Asia Pacific Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: Asia Pacific Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 24: Asia Pacific Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 26: Latin America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 27: Latin America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Workflow, 2021-2034
  • Table 28: Latin America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Latin America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Latin America Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 32: Middle East & Africa Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 33: Middle East & Africa Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Workflow, 2021-2034
  • Table 34: Middle East & Africa Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 35: Middle East & Africa Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 36: Middle East & Africa Chinese Hamster Ovary Cell Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Chinese Hamster Ovary Cell Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034
  • Figure 2: Global Chinese Hamster Ovary Cell Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Chinese Hamster Ovary Cell Market Value Share (%), By Workflow, 2025 & 2034
  • Figure 4: Global Chinese Hamster Ovary Cell Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Chinese Hamster Ovary Cell Market Value Share (%), By End User, 2025 & 2034
  • Figure 6: Global Chinese Hamster Ovary Cell Market Value Share (%), By Region, 2025 & 2034
  • Figure 7: North America Chinese Hamster Ovary Cell Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 8: North America Chinese Hamster Ovary Cell Market Value Share (%), By Offering, 2025
  • Figure 9: North America Chinese Hamster Ovary Cell Market Value (USD billion), By Workflow, 2025 & 2034
  • Figure 10: North America Chinese Hamster Ovary Cell Market Value Share (%), By Workflow, 2025
  • Figure 11: North America Chinese Hamster Ovary Cell Market Value (USD billion), By Application, 2025 & 2034
  • Figure 12: North America Chinese Hamster Ovary Cell Market Value Share (%), By Application, 2025
  • Figure 13: North America Chinese Hamster Ovary Cell Market Value (USD billion), By End User, 2025 & 2034
  • Figure 14: North America Chinese Hamster Ovary Cell Market Value Share (%), By End User, 2025
  • Figure 15: North America Chinese Hamster Ovary Cell Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Chinese Hamster Ovary Cell Market Value Share (%), By Country, 2025
  • Figure 17: Europe Chinese Hamster Ovary Cell Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 18: Europe Chinese Hamster Ovary Cell Market Value Share (%), By Offering, 2025
  • Figure 19: Europe Chinese Hamster Ovary Cell Market Value (USD billion), By Workflow, 2025 & 2034
  • Figure 20: Europe Chinese Hamster Ovary Cell Market Value Share (%), By Workflow, 2025
  • Figure 21: Europe Chinese Hamster Ovary Cell Market Value (USD billion), By Application, 2025 & 2034
  • Figure 22: Europe Chinese Hamster Ovary Cell Market Value Share (%), By Application, 2025
  • Figure 23: Europe Chinese Hamster Ovary Cell Market Value (USD billion), By End User, 2025 & 2034
  • Figure 24: Europe Chinese Hamster Ovary Cell Market Value Share (%), By End User, 2025
  • Figure 25: Europe Chinese Hamster Ovary Cell Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Chinese Hamster Ovary Cell Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Chinese Hamster Ovary Cell Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 28: Asia Pacific Chinese Hamster Ovary Cell Market Value Share (%), By Offering, 2025
  • Figure 29: Asia Pacific Chinese Hamster Ovary Cell Market Value (USD billion), By Workflow, 2025 & 2034
  • Figure 30: Asia Pacific Chinese Hamster Ovary Cell Market Value Share (%), By Workflow, 2025
  • Figure 31: Asia Pacific Chinese Hamster Ovary Cell Market Value (USD billion), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Chinese Hamster Ovary Cell Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Chinese Hamster Ovary Cell Market Value (USD billion), By End User, 2025 & 2034
  • Figure 34: Asia Pacific Chinese Hamster Ovary Cell Market Value Share (%), By End User, 2025
  • Figure 35: Asia Pacific Chinese Hamster Ovary Cell Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Chinese Hamster Ovary Cell Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Chinese Hamster Ovary Cell Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 38: Latin America Chinese Hamster Ovary Cell Market Value Share (%), By Offering, 2025
  • Figure 39: Latin America Chinese Hamster Ovary Cell Market Value (USD billion), By Workflow, 2025 & 2034
  • Figure 40: Latin America Chinese Hamster Ovary Cell Market Value Share (%), By Workflow, 2025
  • Figure 41: Latin America Chinese Hamster Ovary Cell Market Value (USD billion), By Application, 2025 & 2034
  • Figure 42: Latin America Chinese Hamster Ovary Cell Market Value Share (%), By Application, 2025
  • Figure 43: Latin America Chinese Hamster Ovary Cell Market Value (USD billion), By End User, 2025 & 2034
  • Figure 44: Latin America Chinese Hamster Ovary Cell Market Value Share (%), By End User, 2025
  • Figure 45: Latin America Chinese Hamster Ovary Cell Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Chinese Hamster Ovary Cell Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Chinese Hamster Ovary Cell Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 48: Middle East & Africa Chinese Hamster Ovary Cell Market Value Share (%), By Offering, 2025
  • Figure 49: Middle East & Africa Chinese Hamster Ovary Cell Market Value (USD billion), By Workflow, 2025 & 2034
  • Figure 50: Middle East & Africa Chinese Hamster Ovary Cell Market Value Share (%), By Workflow, 2025
  • Figure 51: Middle East & Africa Chinese Hamster Ovary Cell Market Value (USD billion), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa Chinese Hamster Ovary Cell Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa Chinese Hamster Ovary Cell Market Value (USD billion), By End User, 2025 & 2034
  • Figure 54: Middle East & Africa Chinese Hamster Ovary Cell Market Value Share (%), By End User, 2025
  • Figure 55: Middle East & Africa Chinese Hamster Ovary Cell Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Chinese Hamster Ovary Cell Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Chinese Hamster Ovary Cell Market Share (%), by Company, 2025